Construction Business Review Conferences
Precision Medicine Asia 2026, a two-day conference scheduled for October 21-22, 2026, in Taiwan. This exceptional event will gather top experts, innovators, and industry leaders to explore the transformative possibilities of precision medicine and drug discovery in Asia. Uncover the extraordinary potential of precision medicine at this year’s annual conference, where tailored treatments, based on genetics, environment, and lifestyle factors, take the spotlight. This dynamic programme is featuring keynote presentations, panel discussions and poster sessions, all designed to showcase the latest innovations and practical applications in precision medicine area.
Precision Medicine Asia 2026, a two-day conference scheduled for October 21-22, 2026, in Taiwan. This exceptional event will gather top experts, innovators, and industry leaders to explore the transformative possibilities of precision medicine and drug discovery in Asia. Uncover the extraordinary potential of precision medicine at this year’s annual conference, where tailored treatments, based on genetics, environment, and lifestyle factors, take the spotlight. This dynamic programme is featuring keynote presentations, panel discussions and poster sessions, all designed to showcase the latest innovations and practical applications in precision medicine area.
Chinese Society of Cell & Gene Therapy (CSGCT) is a non-profit professional organization dedicated to advancing innovation and collaboration in the field of cell and gene therapy.CSGCT brings together leaders from academia, healthcare, industry, regulatory, and investment communities to promote scientific excellence, accelerate clinical translation, and support the sustainable growth of the CGT ecosystem.By fostering international collaboration and cross-sector partnerships, CSGCT aims to connect China with the global CGT community and help deliver innovative therapies to patients around the world.Our mission is to advance science, enable innovation, and improve lives through the development of cell and gene therapy.
BIO Asia–Taiwan Exhibition 2026 takes place July 16–19 at TaiNEX 1, Taipei, Taiwan. Bringing together 22 countries, 900 companies, and 2,300 booths, it is one of Asia's leading biotechnology exhibitions.
The RNA Leaders program features scientific tracks covering in-depth development strategies, trends and technologies across the entire long and small RNA spectrum and areas of focus below RNA Leaders offers a variety of different social environments to enhance your networking opportunities and make the most of your presence this October.
RNA Therapeutics and Manufacturing Asia 2026 will bring together experts, researchers, and industry leaders to explore the latest trends in RNA therapeutics and manufacturing. Discussions will cover mRNA, RNA interference (RNAi), antisense oligonucleotides, scalable manufacturing solutions, optimizing RNA synthesis, purification, and quality control, while exploring cost-effective, high-yield production technologies. With Asia emerging as a key hub for RNA innovation, this conference offers a vital platform for professionals to share insights, tackle challenges, and drive the future of RNA-based therapies.
ChinaBio® Partnering Forum is the largest and most productive life science partnering event in China. To be held as a 2 days in-person, 2 days virtually, April 28–29, 2026, and May 6–7, 2026, the conference will bring together biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for four days of successful partnering.
Analytica Hanoi introduces the analytica brand to the capital city. As the official spinoff of analytica Vietnam, this inaugural exhibition is tailored to meet the specific needs of northern Vietnam’s fast-growing laboratory and analytical sectors. It provides a targeted platform for international and local companies to engage directly with key buyers, manufacturers, research institutions, and government representatives in the north. Bringing the strength and reputation of the analytica brand to Hanoi, the 2026 launch offers timely access to one of Vietnam’s most dynamic regional markets.
BIOCHINA 2026(11th) will be held from March 12–14 at the Suzhou International Expo Center. Following the success of BIOCHINA 2025 (10th), which welcomed 30,000 attendees in Suzhou, BIOCHINA continues its journey of boundless innovation and collaborative growth! Over the past decade, BIOCHINA has expanded from China's thriving biopharmaceutical sector to the world stage, establishing an international platform for industry connectivity and uniting global expertise to advance collaboration. Through technological breakthroughs, commercial implementation, capital support, and ecosystem integration, BIOCHINA has witnessed China's innovative drug industry evolve from following to leading, progressing alongside the industry and the times.
The RNA therapeutics industry is poised for a transformative 2025, driven by groundbreaking technological advancements, expanding clinical applications, and a rapidly growing pipeline of innovative therapies. Following the remarkable success of mRNA-based COVID-19 vaccines, the field has seen a surge in investment and research aimed at unlocking RNA's potential for a wide range of therapeutic uses. From targeted cancer treatments to ex vivo gene therapies for rare genetic disorders, the RNA therapeutics sector is experiencing exciting developments that continue to gain momentum.
